1 Day
Source:
سرايا الإخبارية
Source: سرايا الإخبارية
1 Dayسرايا الإخبارية
Source: سرايا الإخبارية
1 DayReady to play
Ready to play
Two international studies, whose findings were published on October 29, 2026, showed that non-invasive tests—including magnetic resonance elastography and FibroScan—were highly accurate in diagnosing advanced fibrosis and cirrhosis, potentially reducing the need for liver biopsies. The studies included more than 1,500 and 350 patients, respectively. The simple blood test Gamma-GT also outperformed the FIB-4 index, leading the researchers to propose using it as a first step, followed by additional tests if needed. Metabolic dysfunction-associated fatty liver disease affects up to one in three adults worldwide, but the proposed approach needs further validation, particularly since diagnosing active hepatitis remains challenging.
Notice: This Is an AI-Generated Summary
Comments (0)